¹⁸F-FDG uptake in PET/CT is a potential predictive biomarker of response to anti-PD-1 antibody therapy in non-small cell lung cancer.

Analysis of patient survival using the Kaplan–Meier method revealed that patients with SUVmax <11.16 tended to have shorter PFS than the patients with SUVmax ≥11.16, although the difference did not reach statistical significance ( P = 0.1671, log-rank test; Fig. 3a ).

also in 111,027 other papers

Consistent with this, patients with high SUVmax also showed a trend towards higher tumour expression of PD-L1, although this association was not statistically significant.

also in 53,322 other papers